Pasithea Therapeutics (KTTA) Shares Issued (2021 - 2026)
Pasithea Therapeutics (KTTA) posted Shares Issued of $129857.0 for Q1 2026, down 92.3% sequentially from $1.7 million in Q4 2025, and down 21.23% YoY from $164846.0 in Q1 2025.
Pasithea Therapeutics (KTTA) Shares Issued (2021 - 2026) Analysis & Trends
Pasithea Therapeutics has reported Shares Issued for 6 years, with the latest figure at $129857.0 in Q1 2026.
- Quarterly Shares Issued fell 21.23% year-over-year to $129857.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $129857.0 (down 21.23% YoY) and the FY2025 annual result came in at $1.7 million, up 7778.14% from the prior year.
- Shares Issued eased to $129857.0 in Q1 2026 per KTTA's latest filing, from $1.7 million in the prior quarter.
- Over five years, Shares Issued peaked at $15.4 million in Q1 2023 and troughed at $21399.0 in Q4 2024.
- A 5-year average of $2.2 million and a median of $164846.0 in 2025 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2023 and 2024: Shares Issued soared 15256.0% in 2023, then slumped 98.8% in 2024.
- Over 5 years, Shares Issued stood at $65000.0 in 2022, then jumped by 52.31% to $99000.0 in 2023, then slumped by 78.38% to $21399.0 in 2024, then surged by 7778.14% to $1.7 million in 2025, then plunged by 92.3% to $129857.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $129857.0, $1.7 million, and $110178.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pasithea Therapeutics | 16.97 Mn | 16.97 Mn | - | 7.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129,857.00 |
| Mar 31, 2026 | 129,857.00 |
| Dec 31, 2025 | 1.69 Mn |
| Dec 31, 2025 | 1.69 Mn |
| Sep 30, 2025 | 110,178.00 |
| Sep 30, 2025 | 110,178.00 |
| Jun 30, 2025 | 151,318.00 |
| Jun 30, 2025 | 151,318.00 |
| Mar 31, 2025 | 164,846.00 |
| Mar 31, 2025 | 164,846.00 |
| Dec 31, 2024 | 21,399.00 |
| Dec 31, 2024 | 21,399.00 |
| Sep 30, 2024 | 185,784.00 |
| Sep 30, 2024 | 185,784.00 |
| Jun 30, 2024 | 769,300.00 |
| Jun 30, 2024 | 769,300.00 |
| Mar 31, 2024 | 184,643.00 |
| Mar 31, 2024 | 184,643.00 |
| Dec 31, 2023 | 99,000.00 |
| Dec 31, 2023 | 99,000.00 |